...
首页> 外文期刊>Journal of proteome research >Advances in proximal fluid proteomics for disease biomarker discovery
【24h】

Advances in proximal fluid proteomics for disease biomarker discovery

机译:用于疾病生物标志物发现的近端蛋白质组学研究进展

获取原文
获取原文并翻译 | 示例
           

摘要

Although serum/plasma has been the preferred source for identification of disease biomarkers, these efforts have been met with little success, in large part due the relatively small number of highly abundant proteins that render the reliable detection of low abundant disease-related proteins challenging due to the expansive dynamic range of concentration of proteins in this sample. Proximal fluid, the fluid derived from the extracellular milieu of tissues, contains a large repertoire of shed and secreted proteins that are likely to be present at higher concentrations relative to plasma/serum. It is hypothesized that many, if not all, proximal fluid proteins exchange with peripheral circulation, which has provided significant motivation for utilizing proximal fluids as a primary sample source for protein biomarker discovery. The present review highlights recent advances in proximal fluid proteomics, including the various protocols utilized to harvest proximal fluids along with detailing the results from mass spectrometry- and antibody-based analyses.
机译:尽管血清/血浆已成为鉴定疾病生物标志物的首选来源,但这些努力取得的成功很少,主要是由于相对少量的高度丰富的蛋白质,使得可靠地检测与疾病相关的低含量的蛋白质具有挑战性。样品中蛋白质浓度的动态范围扩大到最大。近端液体是源自组织细胞外环境的液体,含有大量脱落和分泌的蛋白质,相对于血浆/血清,这些蛋白质可能以更高的浓度存在。假设许多(如果不是全部)近端液体蛋白质与周围循环交换,这为利用近端液体作为蛋白质生物标志物发现的主要样品来源提供了重要动力。本综述着重介绍了近端流体蛋白质组学的最新进展,包括用于收获近端流体的各种方案,并详细介绍了基于质谱和基于抗体的分析的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号